Eli Lilly CEO says company can help 'respond' to national security concerns around essential drugs as tariffs loom

CEO of Eli Lilly and Company David Ricks speaks at the Economic Club of New York on March 12, 2024 in New York City.Eli Lilly CEO Dave Ricks on Thursday said the drugmaker can help "respond" to national security concerns around cheaper essential medicines as pharmaceutical-specific tariffs loom. The Trump administration has opened a Section 232 investigation into how importing certain drugs into the U.S. affects national security – a move widely seen as a prelude to initiating tariffs on pharmaceuticals. It ...